Design of a nationwide survey on palliative care for end-stage heart failure in Japan
Yuma Kurozumi(Hyogo Prefectural Amagasaki General Medical Center), Yukihito Sato(Hyogo Prefectural Amagasaki General Medical Center), Yasuko Takada(National Cerebral and Cardiovascular Center), Taiki Higo(Kyushu University), Norihiko Kotooka(Saga University), Yasushi Sakata(Osaka University), Seiko Maeda(Toyohashi Heart Center), T Takahashi(Hyogo Prefectural Cancer Center), Saori Yamabe(Mitsubishi Kyoto Hospital), Koichi Washida(Kobe Women's University), Dai Yumino, Akihiro Sakashita(Kobe University), Makoto Suzuki(Jichi Medical University), Yasuo Sugano(keiyu Hospital), Shogo Oishi(Tokyo Metropolitan Institute of Public Health), Tomohito Ohtani(The University of Osaka)
Cited by 10
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
TRPP2 and TRPV4 form a polymodal sensory channel complex
|The Journal of Cell Biology|2008|397